Caddie Laberiano-Fernández

Phase II study of durvalumab (anti-PD-L1) and trametinib (MEKi) in microsatellite stable (MSS) metastatic colorectal cancer (mCRC)

Benny Johnson, Cara Haymaker, Edwin R. Parra et al. · Journal for ImmunoTherapy of Cancer · 2022 · 52 citations · Full text

Medicine, Oncology, Pharmacology +17

Phase II trial of neoadjuvant sitravatinib plus nivolumab in patients undergoing nephrectomy for locally advanced clear cell renal cell carcinoma

José A. Karam, Pavlos Msaouel, Cara Haymaker et al. · Nature Communications · 2023 · 48 citations · Full text

Medicine, Oncology, Pharmacology +17

Multi-omics Analysis Reveals Immune Features Associated with Immunotherapy Benefit in Patients with Squamous Cell Lung Cancer from Phase III Lung-MAP S1400I Trial

Edwin R. Parra, Jiexin Zhang, Dzifa Y. Duose et al. · Clinical Cancer Research · 2024 · 41 citations · Full text

Medicine, Immunology, Oncology +17

Genotype-to-Phenotype Associations in the Aggressive Variant Prostate Cancer Molecular Profile (AVPC-m) Components

Rama Soundararajan, Paul V. Viscuse, Patrick G. Pilié et al. · Cancers · 2022 · 25 citations · Full text

Medicine, Molecular Genetics, Oncology +17

Pathology Quality Control for Multiplex Immunofluorescence and Image Analysis Assessment in Longitudinal Studies

Rossana Lazcano, Frank Rojas, Caddie Laberiano-Fernández et al. · Frontiers in Molecular Biosciences · 2021 · 12 citations · Full text

Medicine, Oncology, Pathology +17